Drug approved to treat Dementia
The Food and Drug Administration approved Novartis AG's Exelon for the treatment of dementia in patients with Parkinson's disease. Exelon is a drug currently on the market to treat mild to moderate
The Food and Drug Administration approved Novartis AG's Exelon for the treatment of dementia in patients with Parkinson's disease. Exelon is a drug currently on the market to treat mild to moderate